Zenith Drugs Ltd
NSE: ZENITHDRUG BSE: 92356
₹39.95
(3.90%)
Wed, 08 Apr 2026, 11:00 am
Market Cap653.37M
PE Ratio18.14
Dividend1.31
Health Technology
Pharmaceuticals: Major
24.5KZenith Drugs Cashflow
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Deprecation and amortization | -12.16M | -13.26M | -13.03M | -13.02M | -29.66M |
| Accumulated depreciation, total | -49.86M | -63.11M | -76.12M | -89.29M | -118.94M |
| Cash from operating activities | -5.67M | 30.43M | -67.42M | -158.40M | -54.66M |
| Funds from operations | 44.77M | 44.41M | 66.30M | 106.01M | 101.35M |
| Net income (cash flow) | 30.29M | 31.38M | 51.53M | 95.37M | 71.61M |
| Depreciation & amortization (cash flow) | 12.16M | 13.26M | 13.03M | 13.02M | 29.66M |
| Depreciation/depletion | 12.14M | 13.25M | 13.02M | — | 29.64M |
| Amortization | 22.00K | 17.00K | 13.00K | — | 18.00K |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -13.41M | -12.91M | -18.83M | -39.93M | -20.92M |
| Changes in working capital | -50.45M | -13.98M | -133.72M | -264.41M | -156.01M |
| Cash from investing activities | -14.28M | -52.42M | 1.06M | -53.30M | -314.07M |
| Capital expenditures | -14.28M | -52.42M | -29.09M | -53.30M | -322.83M |
| Capital expenditures - fixed assets | -14.28M | -52.42M | -29.09M | -53.30M | -321.13M |
| Capital expenditures - other assets | 0 | 0 | 0 | -41.01M | -1.71M |
| Cash from financing activities | 34.08M | 33.52M | 72.42M | 297.16M | 283.93M |
| Free cash flow | -19.95M | -21.99M | -96.51M | -211.70M | -375.79M |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800